While devices that stimulate the brain invasively have generally been available since 2002, and devices that do so non-invasively have been available since 2013, in recent years, the U.S. Food and ...
Traveling to and from a clinic or a laboratory for treatment can be difficult and expensive for older Americans. To address this, scientists developed and tested a new training and supervision program ...
HOUSTON, TX, Jan. 23, 2024 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (NXL) (the “Company” or “Nexalin”) (Nasdaq: NXL; NXLIW) today announced that the United States Patent and Trademark Office ...
A noninvasive, home-based brain treatment with transcranial direct current stimulation (tDCS) can reduce pain severity, improve pain-related disability, and enhance endogenous pain modulation in women ...
The U.S. Food and Drug Administration cleared Flow Neuroscience’s at-home electrical stimulation headset for adults with moderate-to-severe depression A trial of 174 people found the device led to ...
MedPage Today on MSN
FDA approves at-home device for treatment-resistant depression
The FDA approved a prescription at-home brain neuromodulation therapy as an adjunctive depression treatment for adults, maker ...
Add Yahoo as a preferred source to see more of our stories on Google. An in-home headset that allows people with depression to send mild electrical current to their brains has been cleared by the Food ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback